+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cough Suppressant Drugs Market - Global Forecast 2026-2032- Product Image
Cough Suppressant Drugs Market - Global Forecast 2026-2032- Product Image
New

Cough Suppressant Drugs Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 180 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4989771
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cough suppressant drugs market is in transition, reflecting new patient expectations, shifting regulations, and expanding digital health solutions. Strategic adaptation is critical as competition intensifies and operational efficiency becomes paramount for sustained growth.

Market Snapshot: Cough Suppressant Drugs Market Growth Trajectory

The cough suppressant drugs market is forecast to grow from USD 2.15 billion in 2025 to USD 2.24 billion in 2026, achieving a CAGR of 4.90%. Market value is expected to reach USD 3.01 billion by 2032. This upward trend is reinforced by the increased adoption of alternative antitussive formulations, ongoing regulatory efforts surrounding opioid-containing remedies, and accelerated deployment of digital health solutions across all regions. As these dynamics reshape both demand and provider strategies, manufacturers and distributors are keenly focused on portfolio innovation, regulatory compliance, and channel optimization to capture new opportunities and remain competitive.

Scope & Segmentation

  • Product Forms: Capsules (including hard and soft gelatin), drops, lozenges (flavored and unflavored), syrups (sugar-based and sugar-free), and tablets (chewable, conventional, orally disintegrating) respond to diverse patient preferences around efficacy, taste, and convenience.
  • Distribution Channels: Hospital pharmacies, retail pharmacies, and online platforms support both prescription and over-the-counter access, aligning with the shift toward more patient-centric purchasing settings.
  • Prescription Status: Includes both over-the-counter and prescription-only options, influencing product labeling, documentation needs, and outreach approaches.
  • Active Ingredients: Benzonatate, codeine, dextromethorphan, diphenhydramine, guaifenesin, and herbal extracts (such as eucalyptus oil, honey, thyme extract) answer demand for non-opioid, standardized, and naturally derived cough solutions.
  • End-User Settings: Cough suppressant administration extends to hospitals, clinics, ambulatory centers, and homecare settings, reflecting the necessity for dosing flexibility and robust supply chain traceability.
  • Geographic Coverage: The Americas, Europe Middle East & Africa, and Asia-Pacific regions each present unique market conditions shaped by local regulation and patient needs, requiring tailored go-to-market models.
  • Key Technology Innovations: Novel taste-masking systems, advanced excipients, sugar-free alternatives, transparent labeling, and omnichannel retail technologies drive improved efficacy, safety, and product differentiation.

Key Takeaways for Decision-Makers

  • Continuous formulation advancements, such as new excipient systems and expanded dosage forms, increase patient compliance and tolerability while responding to evolving therapeutic expectations.
  • Enhanced regulatory oversight of opioid-containing and pediatric cough suppressants is channeling investments into non-opioid medications and validated herbal actives, with an emphasis on robust safety demonstrations.
  • Digital health adoption and telemedicine expansion are shifting patient engagement models, highlighting the importance of clear information on product safety and ingredient transparency.
  • Omnichannel strategies, especially leveraging online pharmacy models, allow organizations to adapt to consumer preferences and regulatory shifts, while maintaining access and operational excellence.
  • Prioritizing sustainability and traceable ingredient sourcing strengthens supplier relationships, as healthcare procurement increasingly considers green credentials and locally sourced APIs.
  • Flexible procurement and manufacturing processes support continuity, helping institutions manage price changes and potential disruptions in global and regional supply chains.

Tariff Impact: Strategic Responses to Evolving Trade Measures

Recent tariff changes have altered sourcing strategies and contract manufacturing relationships within the cough suppressant drugs market. Adjustments in import duties and trade policies are raising cost pressures, prompting many organizations to prioritize local API sourcing, negotiate long-term supplier contracts, and diversify their packaging partnerships. Hospital procurement teams are emphasizing supply consistency and regulatory compliance, while retail and digital channels focus on packaging and pricing realignment to maintain competitiveness. Ensuring trade compliance and optimizing logistics are now integral for upholding reliable partnerships with healthcare stakeholders.

Methodology & Data Sources

This analysis uses a mixed-methods approach, combining insights from in-depth interviews with formulators, clinicians, and procurement professionals with secondary research, including regulatory filings, clinical publications, and trade data. Findings are validated through expert triangulation to ensure the highest relevance and accuracy for decision-makers.

Why This Report Matters

  • Supplies actionable intelligence through detailed segmentation, aiding senior leaders in navigating regulatory, clinical, and commercial challenges.
  • Enables risk mitigation by presenting effects of supply chain shifts, tariffs, and regulatory changes on operational decision-making.
  • Clarifies region-specific dynamics to inform strategic investments in product development, procurement, and channel expansion initiatives.

Conclusion

Robust formulation practices, adaptive commercialization, and ongoing regulatory alignment will drive future competitiveness in the cough suppressant drugs market. Integrated supply chains and agile channel strategies will support portfolio resilience and responsiveness to global healthcare demands.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cough Suppressant Drugs Market, by Product Form
8.1. Capsule
8.1.1. Hard Capsule
8.1.2. Soft Gelatin Capsule
8.2. Drop
8.3. Lozenge
8.3.1. Flavored
8.3.2. Unflavored
8.4. Syrup
8.4.1. Sugar-Based
8.4.2. Sugar-Free
8.5. Tablet
8.5.1. Chewable Tablet
8.5.2. Conventional Tablet
8.5.3. Orally Disintegrating Tablet
9. Cough Suppressant Drugs Market, by Prescription Status
9.1. Over The Counter
9.2. Prescription
10. Cough Suppressant Drugs Market, by Active Ingredient
10.1. Benzonatate
10.2. Codeine
10.3. Dextromethorphan
10.4. Diphenhydramine
10.5. Guaifenesin
10.6. Herbal Extracts
10.6.1. Eucalyptus Oil
10.6.2. Honey
10.6.3. Thyme Extract
11. Cough Suppressant Drugs Market, by Distribution Channel
11.1. Hospital Pharmacies
11.2. Online Pharmacies
11.3. Retail Pharmacies
12. Cough Suppressant Drugs Market, by End User
12.1. Ambulatory Center
12.2. Clinic
12.3. Homecare
12.4. Hospital
13. Cough Suppressant Drugs Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Cough Suppressant Drugs Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Cough Suppressant Drugs Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Cough Suppressant Drugs Market
17. China Cough Suppressant Drugs Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AstraZeneca plc
18.6. Aurobindo Pharma Limited
18.7. Bayer Ag
18.8. Boehringer Ingelheim International GmbH
18.9. GlaxoSmithKline plc
18.10. Haleon plc
18.11. Johnson & Johnson
18.12. Kenvue Inc.
18.13. Merck & Co., Inc.
18.14. Novartis AG
18.15. Perrigo Company plc
18.16. Pfizer Inc.
18.17. Prestige Consumer Healthcare Inc.
18.18. Reckitt Benckiser Group plc
18.19. Sanofi S.A.
18.20. Sun Pharmaceutical Industries Limited
18.21. Teva Pharmaceutical Industries Ltd.
18.22. The Procter & Gamble Company
18.23. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL COUGH SUPPRESSANT DRUGS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HARD CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HARD CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HARD CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SOFT GELATIN CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SOFT GELATIN CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SOFT GELATIN CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DROP, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DROP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DROP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FLAVORED, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FLAVORED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FLAVORED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY UNFLAVORED, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY UNFLAVORED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY UNFLAVORED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUGAR-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUGAR-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUGAR-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUGAR-FREE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUGAR-FREE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUGAR-FREE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CHEWABLE TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CHEWABLE TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CHEWABLE TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CONVENTIONAL TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CONVENTIONAL TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CONVENTIONAL TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ORALLY DISINTEGRATING TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ORALLY DISINTEGRATING TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ORALLY DISINTEGRATING TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY OVER THE COUNTER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY OVER THE COUNTER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DIPHENHYDRAMINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DIPHENHYDRAMINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DIPHENHYDRAMINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GUAIFENESIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GUAIFENESIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GUAIFENESIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY EUCALYPTUS OIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY EUCALYPTUS OIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY EUCALYPTUS OIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HONEY, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HONEY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HONEY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY THYME EXTRACT, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY THYME EXTRACT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY THYME EXTRACT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AMBULATORY CENTER, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AMBULATORY CENTER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AMBULATORY CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. EUROPE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. EUROPE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 155. EUROPE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 156. EUROPE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2032 (USD MILLION)
TABLE 157. EUROPE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 158. EUROPE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 159. EUROPE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 160. EUROPE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 161. EUROPE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
TABLE 162. EUROPE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 163. EUROPE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 177. AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 178. AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2032 (USD MILLION)
TABLE 179. AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 180. AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 181. AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 182. AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 183. AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
TABLE 184. AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 198. ASEAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. ASEAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 200. ASEAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 201. ASEAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2032 (USD MILLION)
TABLE 202. ASEAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 203. ASEAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 204. ASEAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 205. ASEAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 206. ASEAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
TABLE 207. ASEAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 208. ASEAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. GCC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. GCC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 211. GCC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 212. GCC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2032 (USD MILLION)
TABLE 213. GCC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 214. GCC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 215. GCC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 216. GCC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 217. GCC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
TABLE 218. GCC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 219. GCC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. BRICS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. BRICS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 233. BRICS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 234. BRICS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2032 (USD MILLION)
TABLE 235. BRICS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 236. BRICS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 237. BRICS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 238. BRICS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 239. BRICS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
TABLE 240. BRICS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 241. BRICS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 242. G7 COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 243. G7 COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 244. G7 COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 245. G7 COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2032 (USD MILLION)
TABLE 246. G7 COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 247. G7 COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 248. G7 COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 249. G7 COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 250. G7 COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
TABLE 251. G7 COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 252. G7 COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 253. NATO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 254. NATO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 255. NATO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 256. NATO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2032 (USD MILLION)
TABLE 257. NATO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 258. NATO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 259. NATO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 260. NATO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 261. NATO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
TABLE 262. NATO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 263. NATO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 264. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 265. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 266. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 267. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 276. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 277. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 278. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 279. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2032 (USD MILLION)
TABLE 280. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2032 (USD MILLION)
TABLE 281. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 282. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2032 (USD MILLION)
TABLE 283. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 284. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
TABLE 285. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 286. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Cough Suppressant Drugs market report include:
  • AstraZeneca plc
  • Aurobindo Pharma Limited
  • Bayer Ag
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline plc
  • Haleon plc
  • Johnson & Johnson
  • Kenvue Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Perrigo Company plc
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.
  • Reckitt Benckiser Group plc
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • The Procter & Gamble Company
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages180
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.24 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.01 Billion
Compound Annual Growth Rate4.9%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Cough Suppressant Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Cough Suppressant Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 179 Pages
  • Global
From
Cough Syrup Market Report by Product Type (Expectorants, Cough Suppressants/Antitussives, Combination Medications), Age Group (Pediatric, Adult), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), and Region 2025-2033 - Product Image

Cough Syrup Market Report by Product Type (Expectorants, Cough Suppressants/Antitussives, Combination Medications), Age Group (Pediatric, Adult), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), and Region 2025-2033

  • Report
  • 141 Pages
  • Global
From
Cough Remedies - Global Strategic Business Report - Product Image

Cough Remedies - Global Strategic Business Report

  • Report
  • 274 Pages
  • Global
From
Cough Syrups - Global Strategic Business Report - Product Image

Cough Syrups - Global Strategic Business Report

  • Report
  • 377 Pages
  • Global
From
Cough Syrups Global Market Report 2025 - Product Image

Cough Syrups Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From

About the Market

The Antitussive market is a subset of the Cough and Cold Drugs market, which is composed of medications used to treat symptoms of the common cold, such as cough, sore throat, and congestion. Antitussives are a type of cough suppressant, which work by reducing the urge to cough and suppressing the reflex that causes coughing. Common ingredients in antitussives include dextromethorphan, codeine, and pholcodine. Antitussives are available in a variety of forms, including syrups, tablets, capsules, and lozenges. They are available both over-the-counter and by prescription, depending on the active ingredient. Some companies in the Antitussive market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.